More flexibility on reporting to federal agencies about injuries to research subjects.
Maloney
Dennis M
DM
The Deem Corporation, P.O. Box 44069, Omaha, NE 68144, USA.
D002986:Clinical Trials as Topic / Q000009:adverse effects* / Q000331:legislation & jurisprudence; D035082:Federal Government; D015316:Genetic Therapy / Q000009:adverse effects*; D033161:Government Regulation; D006801:Humans; D019221:Mandatory Reporting; D009316:National Institutes of Health (U.S.); D035842:Research Subjects; D014481:United States; D014486:United States Food and Drug Administration